PDF
ZENODO
Published
2025-06-18
Section
Articles
How to Cite
How to Cite
Modern Treatment Approaches for Vasomotor and Allergic Rhinitis: Clinical Guidelines and Innovative Strategies
Otaqulov Otabek
Assistant, Department of Surgical Diseases, Central Asian Medical University, Fergana, Uzbekistan
Tokhirjon Abdunazarov
Assistant, Department of Surgical Diseases, Central Asian Medical University, Fergana, Uzbekistan
Komolidinov Bobur
Assistant, Department of Surgical Diseases, Central Asian Medical University, Fergana, Uzbekistan
Keywords: Allergic rhinitis, Vasomotor rhinitis, Antihistamines, Nasal corticosteroids, Immunotherapy, Biologic therapy, Conchotomy, EAACI, ARIA, Rhinology, Upper airway diseases
Abstract
Vasomotor and allergic rhinitis are common upper airway conditions that significantly affect patients’ quality of life and impose a substantial socio-economic burden. This article provides a comprehensive overview of their modern treatment strategies, based on current international guidelines. The pathogenesis, diagnostic approaches, and therapeutic options—ranging from pharmacotherapy (antihistamines, corticosteroids, antileukotrienes) to biologics and surgical methods—are thoroughly discussed. Emphasis is placed on the integration of innovative treatments such as specific immunotherapy, botulinum toxin injections, and minimally invasive surgical techniques. The review highlights evidence-based recommendations from leading organizations such as EAACI and ARIA, aiming to optimize patient outcomes through a personalized and multidisciplinary approach.
References
• Bousquet J et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. Allergy, 2020
• Global Atlas of Allergy. EAACI, 2022
• WAO White Book on Allergy, 2021
• Meltzer EO, Bukstein DA. Pharmacologic treatment of allergic rhinitis. JACI, 2022
• Fokkens WJ et al. EPOS 2020 guidelines for sinonasal diseases
• Ministry of Health, Uzbekistan. 2022 National ENT Disease Statistics
• WHO & CDC: Allergic Disease Prevalence, 2023 Review
